Page last updated: 2024-11-10

4-dimethylaminocinnamaldehyde

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID5284506
CHEMBL ID2299418
CHEBI ID167815
SCHEMBL ID351371
SCHEMBL ID374619
MeSH IDM0070130

Synonyms (64)

Synonym
STL284482
CHEBI:167815
(e)-3-[4-(dimethylamino)phenyl]prop-2-enal
(2e)-3-[4-(dimethylamino)phenyl]prop-2-enal
inchi=1/c11h13no/c1-12(2)11-7-5-10(6-8-11)4-3-9-13/h3-9h,1-2h3/b4-3
p-(dimethylamino)cinnamaldehyde
4-(dimethylamino)cinnamaldehyde ,
p-dimethylaminocinnamic aldehyde
nsc62138
6203-18-5
2-propenal, 3-[4-(dimethylamino)phenyl]-
4-dimethylaminocinnamaldehyde
4-dimethylcinnamaldehyde
cinnamaldehyde, p-(dimethylamino)-
nsc-62138
p-n,n-dimethylaminocinnamaldehyde
4-(dimethylamino)cinnamaldehyde, chromogenic reagent for indoles and flavanols
ccris 3773
p-dimethylaminocinnamaldehyde
2-propenal, 3-(4-(dimethylamino)phenyl)-
einecs 228-267-0
nsc 62138
3-(4-(dimethylamino)phenyl)-2-propenal
3-[4-(dimethylamino)phenyl]-2-propenal
3-[4-(dimethylamino)phenyl]acrylaldehyde
D0648
(n,n-dimethylamino)cinnamaldehyde
AKOS003220800
A833548
(e)-3-[4-(dimethylamino)phenyl]-2-propenal
trans-4-(n,n-dimethylamino)cinnamaldehyde
(e)-3-(4-dimethylaminophenyl)prop-2-enal
2-propenal, 3-(4-(dimethylamino)phenyl)-, (2e)-
2-propenal, 3-(4-(dimethylamino)phenyl)-, (e)-
unii-9rsi7wz9f0
cinnamaldehyde, p-(dimethylamino)-, (e)-
trans-p-(dimethylamino)cinnamaldehyde
9rsi7wz9f0 ,
2-propenal, 3-[4-(dimethylamino)phenyl]-, (2e)-
20432-35-3
SCHEMBL351371
CHEMBL2299418
3-(4-(dimethylamino)phenyl)acrylaldehyde
SCHEMBL374619
4-(n,n-dimethylamino)cinnamaldehyde
4-dimethylaminocinnamic aldehyde
J-610047
Q-200405
(e)-3-(4-(dimethylamino)phenyl)acrylaldehyde
mfcd00007002
DTXSID9022237
dmaca reagent, for microbiology
4-(dimethylamino)cinnamaldehyde, >=98.0% (hplc)
(para-dimethylamino)cinnamaldehyde
F1967-0937
Q5205585
(e)-4-(dimethylamino)cinnamaldehyde
CS-W017445
AS-14579
4-(dimethylamino)-cinnamaldehyde
D77810
EN300-250434
EN300-6494221
Z3064090061

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Determinations on dosage forms of the drugs, using PDAC and PDAB reagents, agreed well with results of determinations by official pharmacopoeial methods."( Colorimetric determination of sympathomimetic amines methyldopa and noradrenaline.
Abou Ouf, A; Salem, FB; Walash, MI,
)
0.13
"The objective of this study was to validate an improved 4-dimethylaminocinnamaldehyde (DMAC) colorimetric method using a commercially available standard (procyanidin A2), for the standard method for quantification of proanthocyanidins (PACs) in cranberry powders, in order to establish dosage guidelines for the uropathogenic bacterial anti-adhesion effect of cranberry."( Multi-laboratory validation of a standard method for quantifying proanthocyanidins in cranberry powders.
Fan, E; Howell, A; Ji, H; Nio, C; Payne, MJ; Prior, RL; Reed, J, 2010
)
0.61
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
cinnamaldehydesAn enal based on a cinnamaldehyde skeleton and its substituted derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (60)

TimeframeStudies, This Drug (%)All Drugs %
pre-199025 (41.67)18.7374
1990's7 (11.67)18.2507
2000's9 (15.00)29.6817
2010's17 (28.33)24.3611
2020's2 (3.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 34.73

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index34.73 (24.57)
Research Supply Index4.19 (2.92)
Research Growth Index4.61 (4.65)
Search Engine Demand Index43.75 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (34.73)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (3.08%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other63 (96.92%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]